← Back to Aspira Pathlab & Diagnostics Limited Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

ASPIRAHealthcare Service Provider

Aspira Pathlab & Diagnostics Limited — Financial Ratios & Key Metrics

₹55.85

-5.60%

P/E Ratio29.92xIndustry: 39.28x

ROE32.96%Return on equity

ROCE17.04%Return on capital

Debt/Equity1.12High debt

💎

Valuation & Profitability

P/E Ratio

29.92x

Industry Average P/E

39.28x

Dividend Yield

0.00%

Market Cap

₹71.80 (Cr)

Sales Growth 5Y

N/A

Profit Growth 5Y

N/A

EPS Growth 5Y

N/A

OPM 5Y Avg

N/A

📉

Price Returns

1 Month

+14.87%

3 Months

+14.18%

6 Months

+27.44%

1 Year

-10.58%

52W Low

₹50

Current

₹56

52W High

₹81

18% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹61

▼ Price below SMA 50 — Bearish

SMA 200

₹62

▼ Long-term downtrend

Volume Signal

188% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Aspira Pathlab & Diagnostics Limited

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Healthcare Service Provider Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.